EarningsQ2 2026 Earnings Report
DE:CS6 Q2 2026 EPS Results
Actual EPS€0.15
Consensus EPS€0.05
Beat/MissBeat by +€0.10
One Year Ago EPS€0.12
DE:CS6 Q2 2026 Revenue Results
Actual Revenue€762.99M
Expected Revenue€749.21M
Beat/MissBeat by +€13.78M
YoY Revenue Growth+2.70%
Earnings Announcement Details
QuarterQ2 2026
Date08/06/2026
TimeBefore Open
Conference CallThursday, August 6, 2026
DE:CS6 Upcoming Earnings
Cascades's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:CS6 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed a generally positive operational and financial trajectory driven by sequential improvements in both Packaging and Tissue, record production at multiple mills, meaningful sequential increases in sales, EBITDA and cash flow, progress on profitability programs and asset monetization, and clear price actions planned to support margins. Offsetting factors include ongoing raw material and transportation cost inflation, a modest year-over-year EBITDA decline in Tissue, specific financial losses, unchanged leverage at 3.3x, and potential downside from newly announced U.S. tariffs (assessment underway, estimated up to 5% of adjusted EBITDA run rate). On balance, reported operational momentum, improving cash generation, and management’s mitigation and pricing actions outweigh the headwinds discussed.Company Guidance
Packaging Sequential Sales and EBITDA Growth
Packaging sales rose to $772 million, up 8% sequentially, and adjusted EBITDA increased 16% sequentially to $120 million, with EBITDA margin improving to 15.5% from 14.4% in Q1 2026.
Strong Shipment and Market Share Performance
Total Packaging shipments increased 9% sequentially to 426,000 tons; box shipments rose 6% sequentially (8.4% ex-sold West Coast plant) and on a comparable asset basis box shipments were up 5.8% year-over-year versus the industry increase of 2.4%.
Tissue Sequential Improvement
Tissue sales increased to $409 million, up 7.6% sequentially, and adjusted EBITDA improved 6% sequentially to $35 million, with shipments up 7% sequentially to 121,000 tons (retail +2%, away-from-home +16%).
Record Production and Utilization
Record production achieved at Greenpac and at Pryor; Bear Island operated at ~95% of total production capacity for the quarter (with July even stronger).
Improved Earnings Per Share and Cash Flow
Reported Q2 net earnings per share were $0.21 (versus net loss per share of $0.03 in Q2 2025); adjusted EPS was $0.24 (up from $0.19 YoY and $0.07 QoQ). Adjusted cash flow from operations was $123 million, up 22% year-over-year.
Profitability Improvement Program Delivering
Profitability initiatives realized $30 million of benefits in 2025 and an estimated further $25 million captured so far in 2026 (total ~$55 million).
Progress on Asset Monetization and Liquidity
Proceeds from business and asset disposals totaled $105 million in 2026 (including $9 million Lachine sale); $163 million realized against $230 million monetization target; available liquidity under credit facility was $737 million.
Price Increases and H2 EBITDA Outlook
Announced price increases of $110/ton on linerboard and white paper grades and $140/ton on medium effective Sept 8; company expects consolidated sequential improvement in Q3 and annual run-rate adjusted EBITDA to exceed $600 million in H2 2026, with Packaging Q3 adjusted EBITDA guidance of $135–140 million.
DE:CS6 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed